# pathway_0159

[All questions](../README.md) · [Summary](../SUMMARY.md) · [Method](../METHOD.md) · [Exact reviewer input](../inputs/pathway_0159.txt)

**Task:** `pathway`  
**Expected answer:** **A** — Antifungal biosynthesis. .

| Reviewer | Expected-answer support | Reasoning versus lookup |
|---|---|---|
| GPT-6 Luna | supported | lookup-dependent |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent |

The reviewers assess the question and its expected answer. Their agreement is not expert confirmation. An unusable review is an output failure, not a finding that the question is wrong.

## Complete original question

```text
[Protein Sequence]
MSKIAQPTATDVGAMYDNHTDLMTDIMAGFIHVGYWEDPENPTETIELATERMTLEVLNRLRPSPGQHILDVGCGTGKTAASIATTHDVSITGITVSNHQIEVARKTYEALVETGKLNFQYADAMQLPLANASFDGAYAIESIVHMNDRRAALSNIARVLRPGSRLSIADLVLDDGCPDPDAIANWHELFQVPALISADKLKELLTETGFRVLECVDIRQHIRPICGVMDKKGLQVGGEVGKTLRGVAASLHGLEELGYILLVAERV

[Multiple Choices]
A. Antifungal biosynthesis. .
B. Secondary metabolite biosynthesis
C. protein ubiquitination. .
D. spheroidene biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Reviewer assessments

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The matched-sequence UniProt record annotates the pathway as “Antifungal biosynthesis,” both in the current entry and in an archived entry available before the historical cutoff. This supports the key as a database annotation; the cited evidence is a curated assertion, not independent experimental validation in the supplied excerpts.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has a glycine-rich motif consistent with a SAM-dependent methyltransferase, which supports a biosynthetic enzyme role and makes ubiquitination or spheroidene biosynthesis less plausible. That transferable inference does not identify the enzyme’s particular product or distinguish antifungal biosynthesis from the broader secondary-metabolite category.


**Missing item-specific fact**

> A target-specific assignment connecting this methyltransferase to antifungal-product biosynthesis, rather than merely to secondary-metabolite biosynthesis.


**Reason**

> Family-level sequence features can narrow the options, but do not meaningfully resolve A versus B: an antifungal biosynthetic pathway can also be described as secondary-metabolite biosynthesis. Selecting the specific pathway label requires information about this protein’s pathway or product association that is absent from the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Antifungal biosynthesis is a kind of secondary-metabolite biosynthesis, so both options can describe the protein’s pathway at different levels of specificity. A is the more specific supported annotation, but the choices are not mutually exclusive as worded.


### Important caveats

- The source evidence matches the supplied sequence, but its pathway assertion is database annotation supported by a cited publication; the excerpts do not independently establish experimental validation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a glycine-rich motif consistent with a SAM-dependent methyltransferase, which supports a biosynthetic enzyme role and makes ubiquitination or spheroidene biosynthesis less plausible. That transferable inference does not identify the enzyme’s particular product or distinguish antifungal biosynthesis from the broader secondary-metabolite category.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "A target-specific assignment connecting this methyltransferase to antifungal-product biosynthesis, rather than merely to secondary-metabolite biosynthesis.",
    "reason": "Family-level sequence features can narrow the options, but do not meaningfully resolve A versus B: an antifungal biosynthetic pathway can also be described as secondary-metabolite biosynthesis. Selecting the specific pathway label requires information about this protein’s pathway or product association that is absent from the input."
  },
  "case_id": "pathway_0159",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The matched-sequence UniProt record annotates the pathway as “Antifungal biosynthesis,” both in the current entry and in an archived entry available before the historical cutoff. This supports the key as a database annotation; the cited evidence is a curated assertion, not independent experimental validation in the supplied excerpts."
  },
  "important_caveats": [
    "The source evidence matches the supplied sequence, but its pathway assertion is database annotation supported by a cited publication; the excerpts do not independently establish experimental validation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Antifungal biosynthesis is a kind of secondary-metabolite biosynthesis, so both options can describe the protein’s pathway at different levels of specificity. A is the more specific supported annotation, but the choices are not mutually exclusive as worded."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0159",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched-sequence UniProt record annotates the pathway as “Antifungal biosynthesis,” both in the current entry and in an archived entry available before the historical cutoff. This supports the key as a database annotation; the cited evidence is a curated assertion, not independent experimental validation in the supplied excerpts.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has a glycine-rich motif consistent with a SAM-dependent methyltransferase, which supports a biosynthetic enzyme role and makes ubiquitination or spheroidene biosynthesis less plausible. That transferable inference does not identify the enzyme’s particular product or distinguish antifungal biosynthesis from the broader secondary-metabolite category.",
    "missing_item_specific_fact": "A target-specific assignment connecting this methyltransferase to antifungal-product biosynthesis, rather than merely to secondary-metabolite biosynthesis.",
    "reason": "Family-level sequence features can narrow the options, but do not meaningfully resolve A versus B: an antifungal biosynthetic pathway can also be described as secondary-metabolite biosynthesis. Selecting the specific pathway label requires information about this protein’s pathway or product association that is absent from the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Antifungal biosynthesis is a kind of secondary-metabolite biosynthesis, so both options can describe the protein’s pathway at different levels of specificity. A is the more specific supported annotation, but the choices are not mutually exclusive as worded."
  },
  "important_caveats": [
    "The source evidence matches the supplied sequence, but its pathway assertion is database annotation supported by a cited publication; the excerpts do not independently establish experimental validation."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV2 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000305 (inferred from PubMed:33857369). The protein is described as 'Lanomycin biosynthesis cluster protein 3' and an 'O-methyltransferase' (EC 2.1.1.-). The historical record (H3) confirms: 'CC -!- PATHWAY: Antifungal biosynthesis.' The sequence matches the benchmark input exactly (267 aa, SHA256 confirmed). The annotation is based on a 2021 JACS study characterizing lanomycin biosynthetic gene clusters.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a clear Rossmann-fold methyltransferase motif (GCGTGKT at residues ~65-71), identifying it as a SAM-dependent O-methyltransferase (~267 aa, Class I). This reliably eliminates C (protein ubiquitination requires RING/HECT/RBR domains, absent here) and D (spheroidene biosynthesis involves phytoene synthases, carotenoid desaturases, and lycopene cyclases, not methyltransferases). However, distinguishing A (Antifungal biosynthesis) from B (Secondary metabolite biosynthesis) from sequence alone is extremely difficult: both are valid UniProt pathway categories under which a fungal O-methyltransferase in a biosynthetic gene cluster could be classified. The specific assignment to 'Antifungal biosynthesis' depends on knowing that the methylated product (lanomycin) exhibits antifungal/CYP51-inhibitory activity—a biological property of the downstream product, not an intrinsic feature readable from the enzyme's sequence.


**Missing item-specific fact**

> The specific biological activity of the natural product synthesized by this methyltransferase (lanomycin's antifungal/CYP51-inhibitory activity) and the UniProt-specific pathway classification decision that places this BGC under 'Antifungal biosynthesis' rather than the broader 'Secondary metabolite biosynthesis' category.


**Reason**

> While the methyltransferase fold eliminates C and D via transferable knowledge of enzyme families, the A-vs-B distinction requires knowledge of the specific natural product's biological activity (antifungal) and the UniProt curation decision to assign a narrow pathway label. Sequence features of the enzyme (Rossmann fold, size, methylation motif) are equally consistent with any secondary metabolite biosynthetic pathway and do not encode information about the product's pharmacological activity.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> A fungal O-methyltransferase in a natural product biosynthetic gene cluster could reasonably be classified under either 'Antifungal biosynthesis' (specific activity-based category) or 'Secondary metabolite biosynthesis' (general biosynthetic category) in UniProt's pathway ontology. The distinction depends on the curated biological activity of the end product, which is not inferable from the enzyme sequence alone.


### Important caveats

- The UniProt annotation for P0DXV2 was first released in February 2025 (entry version 1), meaning this protein was not in Swiss-Prot at the time many model training cutoffs occurred.
- The pathway annotation is based on a single 2021 JACS study (PubMed:33857369) using targeted genome mining; it is classified as ECO:0000305 (inferred from a single reference), not independently validated by multiple sources.
- The organism (Pyrenophora dematioidea, a filamentous fungus) is not provided in the model input; recognizing fungal origin from sequence alone is possible but does not by itself resolve A vs B.
- The GCGTGKT motif is a well-known Rossmann-fold SAM-binding signature present in thousands of methyltransferases across all domains of life and across many different pathways.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a clear Rossmann-fold methyltransferase motif (GCGTGKT at residues ~65-71), identifying it as a SAM-dependent O-methyltransferase (~267 aa, Class I). This reliably eliminates C (protein ubiquitination requires RING/HECT/RBR domains, absent here) and D (spheroidene biosynthesis involves phytoene synthases, carotenoid desaturases, and lycopene cyclases, not methyltransferases). However, distinguishing A (Antifungal biosynthesis) from B (Secondary metabolite biosynthesis) from sequence alone is extremely difficult: both are valid UniProt pathway categories under which a fungal O-methyltransferase in a biosynthetic gene cluster could be classified. The specific assignment to 'Antifungal biosynthesis' depends on knowing that the methylated product (lanomycin) exhibits antifungal/CYP51-inhibitory activity—a biological property of the downstream product, not an intrinsic feature readable from the enzyme's sequence.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific biological activity of the natural product synthesized by this methyltransferase (lanomycin's antifungal/CYP51-inhibitory activity) and the UniProt-specific pathway classification decision that places this BGC under 'Antifungal biosynthesis' rather than the broader 'Secondary metabolite biosynthesis' category.",
    "reason": "While the methyltransferase fold eliminates C and D via transferable knowledge of enzyme families, the A-vs-B distinction requires knowledge of the specific natural product's biological activity (antifungal) and the UniProt curation decision to assign a narrow pathway label. Sequence features of the enzyme (Rossmann fold, size, methylation motif) are equally consistent with any secondary metabolite biosynthetic pathway and do not encode information about the product's pharmacological activity."
  },
  "case_id": "pathway_0159",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV2 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000305 (inferred from PubMed:33857369). The protein is described as 'Lanomycin biosynthesis cluster protein 3' and an 'O-methyltransferase' (EC 2.1.1.-). The historical record (H3) confirms: 'CC -!- PATHWAY: Antifungal biosynthesis.' The sequence matches the benchmark input exactly (267 aa, SHA256 confirmed). The annotation is based on a 2021 JACS study characterizing lanomycin biosynthetic gene clusters."
  },
  "important_caveats": [
    "The UniProt annotation for P0DXV2 was first released in February 2025 (entry version 1), meaning this protein was not in Swiss-Prot at the time many model training cutoffs occurred.",
    "The pathway annotation is based on a single 2021 JACS study (PubMed:33857369) using targeted genome mining; it is classified as ECO:0000305 (inferred from a single reference), not independently validated by multiple sources.",
    "The organism (Pyrenophora dematioidea, a filamentous fungus) is not provided in the model input; recognizing fungal origin from sequence alone is possible but does not by itself resolve A vs B.",
    "The GCGTGKT motif is a well-known Rossmann-fold SAM-binding signature present in thousands of methyltransferases across all domains of life and across many different pathways."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "A fungal O-methyltransferase in a natural product biosynthetic gene cluster could reasonably be classified under either 'Antifungal biosynthesis' (specific activity-based category) or 'Secondary metabolite biosynthesis' (general biosynthetic category) in UniProt's pathway ontology. The distinction depends on the curated biological activity of the end product, which is not inferable from the enzyme sequence alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0159",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV2 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000305 (inferred from PubMed:33857369). The protein is described as 'Lanomycin biosynthesis cluster protein 3' and an 'O-methyltransferase' (EC 2.1.1.-). The historical record (H3) confirms: 'CC -!- PATHWAY: Antifungal biosynthesis.' The sequence matches the benchmark input exactly (267 aa, SHA256 confirmed). The annotation is based on a 2021 JACS study characterizing lanomycin biosynthetic gene clusters.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a clear Rossmann-fold methyltransferase motif (GCGTGKT at residues ~65-71), identifying it as a SAM-dependent O-methyltransferase (~267 aa, Class I). This reliably eliminates C (protein ubiquitination requires RING/HECT/RBR domains, absent here) and D (spheroidene biosynthesis involves phytoene synthases, carotenoid desaturases, and lycopene cyclases, not methyltransferases). However, distinguishing A (Antifungal biosynthesis) from B (Secondary metabolite biosynthesis) from sequence alone is extremely difficult: both are valid UniProt pathway categories under which a fungal O-methyltransferase in a biosynthetic gene cluster could be classified. The specific assignment to 'Antifungal biosynthesis' depends on knowing that the methylated product (lanomycin) exhibits antifungal/CYP51-inhibitory activity—a biological property of the downstream product, not an intrinsic feature readable from the enzyme's sequence.",
    "missing_item_specific_fact": "The specific biological activity of the natural product synthesized by this methyltransferase (lanomycin's antifungal/CYP51-inhibitory activity) and the UniProt-specific pathway classification decision that places this BGC under 'Antifungal biosynthesis' rather than the broader 'Secondary metabolite biosynthesis' category.",
    "reason": "While the methyltransferase fold eliminates C and D via transferable knowledge of enzyme families, the A-vs-B distinction requires knowledge of the specific natural product's biological activity (antifungal) and the UniProt curation decision to assign a narrow pathway label. Sequence features of the enzyme (Rossmann fold, size, methylation motif) are equally consistent with any secondary metabolite biosynthetic pathway and do not encode information about the product's pharmacological activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "A fungal O-methyltransferase in a natural product biosynthetic gene cluster could reasonably be classified under either 'Antifungal biosynthesis' (specific activity-based category) or 'Secondary metabolite biosynthesis' (general biosynthetic category) in UniProt's pathway ontology. The distinction depends on the curated biological activity of the end product, which is not inferable from the enzyme sequence alone."
  },
  "important_caveats": [
    "The UniProt annotation for P0DXV2 was first released in February 2025 (entry version 1), meaning this protein was not in Swiss-Prot at the time many model training cutoffs occurred.",
    "The pathway annotation is based on a single 2021 JACS study (PubMed:33857369) using targeted genome mining; it is classified as ECO:0000305 (inferred from a single reference), not independently validated by multiple sources.",
    "The organism (Pyrenophora dematioidea, a filamentous fungus) is not provided in the model input; recognizing fungal origin from sequence alone is possible but does not by itself resolve A vs B.",
    "The GCGTGKT motif is a well-known Rossmann-fold SAM-binding signature present in thousands of methyltransferases across all domains of life and across many different pathways."
  ]
}
```

</details>

## Complete reviewer-only evidence and qualifications

These source excerpts were available to the reviewers. They were not included in the original benchmark-solving input.

**Source applicability:**

```json
{
  "actual_author_source_snapshot": "unknown",
  "benchmark_sequence_length": 267,
  "benchmark_sequence_sha256": "f3d1a7b576e8e74068588d5dcf8c53580e5c8c821185e61a2255d344ca677cac",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_record_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "current_sequence_comparison": "matched",
  "current_source_sequence_length": 267,
  "current_source_sequence_sha256": "f3d1a7b576e8e74068588d5dcf8c53580e5c8c821185e61a2255d344ca677cac",
  "current_status": "retrieved",
  "current_uniprot_release": "2026_03",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "historical_status": "retrieved",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "latest_at_cutoff_sequence_comparison": "matched",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed.",
  "requested_accession": "P0DXV2",
  "selected_historical_entry_version": 4,
  "selected_historical_record_sha256": "295b26b0fe5e1dcaa477e72a562f35a6ec22c74d0c813d34313f57bac078b894",
  "selected_historical_source_sequence_length": 267,
  "selected_historical_source_sequence_sha256": "f3d1a7b576e8e74068588d5dcf8c53580e5c8c821185e61a2255d344ca677cac",
  "selected_historical_version": {
    "accession": "P0DXV2",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "LAN3_PYRDE",
    "sequenceVersion": 1
  }
}
```

**Qualifications:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV2.json)

```json
{
  "evidence_id": "C1",
  "excerpt": "\"P0DXV2\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/primaryAccession",
  "retrieved_utc": "2026-11-01T06:25:16.453642+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV2.json"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV2.json)

```json
{
  "evidence_id": "C2",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/entryAudit",
  "retrieved_utc": "2026-11-01T06:25:16.453642+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV2.json"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV2.json)

```json
{
  "evidence_id": "C3",
  "excerpt": "{\"commonName\":\"Helminthosporium dematioideum\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Dothideomycetes\",\"Pleosporomycetidae\",\"Pleosporales\",\"Pleosporineae\",\"Pleosporaceae\",\"Pyrenophora\"],\"scientificName\":\"Pyrenophora dematioidea\",\"taxonId\":139229}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/organism",
  "retrieved_utc": "2026-11-01T06:25:16.453642+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV2.json"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV2.json)

```json
{
  "evidence_id": "C4",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Lanomycin biosynthesis cluster protein 3\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"2.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"O-methyltransferase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/proteinDescription",
  "retrieved_utc": "2026-11-01T06:25:16.453642+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV2.json"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV2.json)

```json
{
  "evidence_id": "C5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/comments/1",
  "retrieved_utc": "2026-11-01T06:25:16.453642+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV2.json"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV2.json)

```json
{
  "evidence_id": "C6",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"TTI-1096\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/references/0",
  "retrieved_utc": "2026-11-01T06:25:16.453642+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "b67f2b3c042204fbbbfe0e45b5c0ed7e611810123c3f2c8c4d077c649a2bb50d",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV2.json"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV2?format=txt&versions=4)

```json
{
  "entry_version": 4,
  "evidence_id": "H1",
  "excerpt": "ID   LAN3_PYRDE              Reviewed;         267 AA.\nAC   P0DXV2;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=O-methyltransferase {ECO:0000303|PubMed:33857369};\nDE            EC=2.1.1.- {ECO:0000305|PubMed:33857369};\nDE   AltName: Full=Lanomycin biosynthesis cluster protein 3 {ECO:0000303|PubMed:33857369};\nGN   Name=ORF3 {ECO:0000303|PubMed:33857369};\nOS   Pyrenophora dematioidea (Helminthosporium dematioideum).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;\nOC   Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae;\nOC   Pyrenophora.\nOX   NCBI_TaxID=139229;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-01T06:28:20.733004+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 1-14",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "295b26b0fe5e1dcaa477e72a562f35a6ec22c74d0c813d34313f57bac078b894",
  "url": "https://rest.uniprot.org/unisave/P0DXV2?format=txt&versions=4"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV2?format=txt&versions=4)

```json
{
  "entry_version": 4,
  "evidence_id": "H2",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=TTI-1096;\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-01T06:28:20.733004+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 15-23",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "295b26b0fe5e1dcaa477e72a562f35a6ec22c74d0c813d34313f57bac078b894",
  "url": "https://rest.uniprot.org/unisave/P0DXV2?format=txt&versions=4"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV2?format=txt&versions=4)

```json
{
  "entry_version": 4,
  "evidence_id": "H3",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-01T06:28:20.733004+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 34-34",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "295b26b0fe5e1dcaa477e72a562f35a6ec22c74d0c813d34313f57bac078b894",
  "url": "https://rest.uniprot.org/unisave/P0DXV2?format=txt&versions=4"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 159. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
